These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3941750)

  • 1. Parathyroid hormone effect on the fragility of human young and old red blood cells in uremia.
    Malachi T; Bogin E; Gafter U; Levi J
    Nephron; 1986; 42(1):52-7. PubMed ID: 3941750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid content of erythrocytes in uremic patients. Correlation with the age distribution of erythrocytes as assessed by glutamic oxaloacetic transaminase determination.
    Gafter U; Levinsky H; Malachi T; Levi J; Bogin E; Allalouf D
    Nephron; 1985; 40(4):463-6. PubMed ID: 4022218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of parathyroid hormone on osmotic fragility of human erythrocytes.
    Bogin E; Massry SG; Levi J; Djaldeti M; Bristol G; Smith J
    J Clin Invest; 1982 Apr; 69(4):1017-25. PubMed ID: 6281309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical changes associated with the osmotic fragility of young and mature erythrocytes caused by parathyroid hormone in relation to the uremic syndrome.
    Levi J; Malachi T; Djaldetti M; Bogin E
    Clin Biochem; 1987 Apr; 20(2):121-5. PubMed ID: 2955961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell density distribution in uremic patients on acetate and bicarbonate hemodialysis.
    Hampl H; Riedel E; Wendel G; Scigalla P
    Blood Purif; 1990; 8(5):260-7. PubMed ID: 1965410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell osmotic fragility in chronically hemodialyzed patients.
    Wu SG; Jeng FR; Wei SY; Su CZ; Chung TC; Chang WJ; Chang HW
    Nephron; 1998; 78(1):28-32. PubMed ID: 9453400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoiesis and erythrocyte age distribution in hemodialysis patients undergoing erythropoietin therapy.
    Hampl H; Riedel E; Scigalla P; Stabell U; Wendel G
    Blood Purif; 1990; 8(3):117-25. PubMed ID: 2244989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of parathyroid hormone on antioxidant enzyme activity and lipid peroxidation of erythrocytes in five-sixths nephrectomized rats.
    Chen SM; Young TK
    Nephron; 1996; 73(2):235-42. PubMed ID: 8773350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.
    Akmal M; Telfer N; Ansari AN; Massry SG
    J Clin Invest; 1985 Oct; 76(4):1695-8. PubMed ID: 4056047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the osmotic fragility of human erythrocytes and cell age.
    Rifkind JM; Araki K; Hadley EC
    Arch Biochem Biophys; 1983 Apr; 222(2):582-9. PubMed ID: 6847204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of parathyroid hormone on the fragility and enzyme activities of red blood cells from young and mature rabbits.
    Bogin E; Malachi Z; Djaldeti M; Levi J
    J Clin Chem Clin Biochem; 1987 Feb; 25(2):77-82. PubMed ID: 2952752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
    Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
    Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure.
    Docci D; Turci F; Baldrati L
    Nephron; 1985; 41(3):241-5. PubMed ID: 3840575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialic acids of young and old red blood cells in healthy subjects.
    Jakubowska-Solarska B; Solski J
    Med Sci Monit; 2000; 6(5):871-4. PubMed ID: 11208424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related increase in erythrocyte oxidant sensitivity.
    Tyan ML
    Mech Ageing Dev; 1982 Sep; 20(1):25-32. PubMed ID: 7176701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of relation between serum parathyroid hormone levels and erythrocyte osmotic fragility in pediatric patients on peritoneal dialysis.
    Koşan C; Sever L; Arisoy N
    Ren Fail; 2004 Nov; 26(6):683-7. PubMed ID: 15600260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
    Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
    Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone and anaemia--an erythrocyte osmotic fragility study in primary and secondary hyperparathyroidism.
    Foulks CJ; Mills GM; Wright LF
    Postgrad Med J; 1989 Mar; 65(761):136-9. PubMed ID: 2813231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients.
    Ibrahim FF; Ghannam MM; Ali FM
    Ren Fail; 2002 Nov; 24(6):779-90. PubMed ID: 12472200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.